mercredi 4 janvier 2017

Onco Actu du 4 janvier 2017

3.1.1 Tabac - e-cigs

FDA probes dangers of exploding e-cigarette batteries [AP]

4. Dépistage, diagnostic et pronostic

Bayer Develops Companion Diagnostic Test for Cancer Patients Together with Leica Biosystems [Bayer]

Experts call for expansion of molecular imaging in precision cancer care [ecancer news]

4.2 Dép., diag. & prono. - Génome

Thousands Give DNA To Further Crowdsourced Breast Cancer Research Project [Hartford Courant]

Using genomics to improve detection of endometrial cancer [FierceBiotech]

5. Traitements

New cancer drugs offer widely different benefits, study says [FiercePharma]

A lasting immune impression could boost blood cancer treatments [Cancer Research UK]

5.12 Immunothérapies

First Trial Underway, Jounce Preps IPO To Fund Immuno-Oncology Work [Xconomy]

5.12.1 Immunothérapies - partenariats

Bristol-Myers, Bavarian Nordic test Opdivo-plus-vaccine combo in lung cancer [FiercePharma]

5.12.2 Immunothérapies - CAR-T

Kite Pharma Submits Investigational New Drug (IND) Application for KITE-718, an Investigational Next Generation T-Cell Receptor (TCR) Therapy Targeting Cancer Antigens MAGE A3 and MAGE A6 [Kite]

5.2 Pharma

FDA clears Glenmark’s HER2+ cancer drug for Phase I trial [European Pharmaceutical Review]

FDA Grants Bayer Priority Review for Stivarga® (regorafenib) for the Second-Line Systemic Treatment of Liver Cancer [Bayer]

Alessandro Riva, MD, to Join Gilead as Senior Vice President, Hematology and Oncology Therapeutic Area Head [Gilead]

Alessandro Riva exits top Novartis oncology post, heads to a troubled — but wealthy — Gilead [EndPoints]

5.4 Traitements - Economie

NICE backs Roche’s Perjeta, but bars Kadcyla [PharmaTimes]

6. Lutte contre les cancers

The new face of US science [Nature]